Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-Olds

At the request of the FDA, the vaccine makers are expanding their trials with young children.

7/27/2021 6:06:00 AM

At the request of the FDA, the vaccine makers are expanding their trials with young children.

At the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.

to include the possible increased risk.Coronavirus cases are on the rise across the country as the highly contagious delta variant spreads, with cases and deaths overwhelmingly among people who are unvaccinated.The Pfizer-BioNTech vaccine has already been authorized for children 12 and older, and the Moderna vaccine is authorized for those 18 and older.

Long-Silent Facebook Friend Comes Out Of Woodwork With Post Asking About Insulating Windows Liz Cheney: `I was wrong' in opposing gay marriage in past Amateur divers discover 'enormously valuable' hoard of Roman coins

As schools are set to reopen for in-person learning in the fall, the issue of vaccinating students is top of mind for parents, teachers and school staff.Pfizer, which started vaccine trials in children 11 and younger in March, said on its website that it expects to have study results to submit to the FDA for emergency use authorization for 5- to 11-year-olds

. A Pfizer spokesperson told HuffPost that the company has not provided any further updates to its vaccine trial timelines for children.Moderna, which alsostarted vaccine trials in children younger than 12 in March, expects to seek emergency authorization in late 2021 or early 2022, a spokesperson told the Times. headtopics.com

The FDA told HuffPost in a statement that the agency can’t comment on “individual interactions with sponsors” but noted that it works with companies to “ensure the number of participants in clinical trials are of adequate size to enhance the detection of safety signals.”

Moderna did not immediately respond to HuffPost’s request for comment.In a letter to the editor in the Times earlier this month, the director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, wrote that the COVID-19 vaccines authorized in the U.S. have been “thoroughly evaluated” and “meet the FDA’s rigorous standards.”

Read more: HuffPost »

Explore With Perseverance

A 3D interactive experience lets you explore with Perseverance, see closeup images the rover has taken, and key points of interest.

Sickening! There will be a special place in hell for them. Giving a “vaccine” to children that causes heart inflammation and God knows what else in the future. Greed! 🤬 Disgusting! You know this is sooo wrong right? You don’t know the long term effects and you are using children as LAB RATS!!!!! 🤬🤬🤬

Evil! good luck

Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.

Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.

WSJ News Exclusive | Covid-19 Immunity Wanes, but Third Shot Still Rarely Needed, BioNTech CEO SaysCovid-19 immunity wanes in people fully vaccinated with the Pfizer-BioNTech shot, but most still won’t need a third dose, the CEO of BioNTech said good luck Would you like to create a second source of income for yourself from the comfort of your home? It won’t interfere with your job or whatever you do. DM me for more details

FDA Grants Priority Review Status to Pfizer VaccineThe U.S. Food and Drug Administration has granted priority review status to the Pfizer/BioNTech coronavirus vaccine for people 16 and up.

Covid-19 Vaccine Pioneer BioNTech Plans to Make New Malaria and Tuberculosis Shots in AfricaBioNTech said it would invest some of the profits from the Covid-19 vaccine it markets with Pfizer into developing shots for malaria and tuberculosis in Africa, part of the company’s plan to establish a production hub for innovative medicines How’s about a booster for the covid variants? Bullshit Africa dont need their shit 😉

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - studyA mixed vaccination of first AstraZeneca (AZN.L) and then a Pfizer (PFE.N) COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed. Somebody outhere is trying to save AstraZeneca vaccine as many people refuse it. I just mix it today 😅 💉💉